Suppr超能文献

使用单珠单化合物文库对CD21结合肽进行两步荧光筛选以及对N-(2-羟丙基)甲基丙烯酰胺共聚物-肽缀合物的结合特性进行研究。

Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates.

作者信息

Ding Hui, Prodinger Wolfgang M, Kopecek Jindrich

机构信息

Department of Pharmaceutics and Pharmaceutical Chemistry, and Bioengineering, University of Utah, Salt Lake City, Utah 84112, USA.

出版信息

Biomacromolecules. 2006 Nov;7(11):3037-46. doi: 10.1021/bm060508f.

Abstract

Using the one-bead one-compound (OBOC) combinatorial method, four heptapeptide ligands of CD21 receptor, a cell surface marker of malignant B cell lymphoma, were identified with an innovative two-step fluorescence screening method to overcome the limitation caused by autofluorescence of TentaGel resin. The binding affinities of selected peptides, YILIHRN (B1), PTLDPLP (B2), and LVLLTRE (B3), were in the micromolar region as determined by a fluorescence quenching assay. Peptide B1 was conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer via spacers of different lengths, composed of one to four repeats of the 8-amino-3,6-dioxaoctanoic acid (A) group. The evaluation of the biorecognizability of HPMA copolymer-B1 conjugates by the CD21 receptor revealed that increasing the number of repeats of A in the spacer from one to three resulted in continuous improvements in the biorecognition by the CD21 receptor; the increase from three to four repeats showed no significant effect. This work showed the potential of the OBOC combinatorial approach to select peptide ligands as targeting moieties for CD21 specific polymeric drug carriers.

摘要

采用单珠单化合物(OBOC)组合方法,运用创新的两步荧光筛选法,鉴定出了恶性B细胞淋巴瘤的细胞表面标志物CD21受体的四种七肽配体,以克服TentaGel树脂自发荧光造成的局限性。通过荧光猝灭测定法确定,所选肽YILIHRN(B1)、PTLDPLP(B2)和LVLLTRE(B3)的结合亲和力处于微摩尔范围。肽B1通过由8-氨基-3,6-二氧辛酸(A)基团的一至四个重复序列组成的不同长度的间隔臂与N-(2-羟丙基)甲基丙烯酰胺(HPMA)共聚物偶联。通过CD21受体对HPMA共聚物-B1偶联物的生物识别能力评估表明,间隔臂中A的重复次数从一增加到三会导致CD21受体的生物识别能力持续提高;从三增加到四次重复则无显著影响。这项工作展示了OBOC组合方法在选择肽配体作为CD21特异性聚合物药物载体的靶向部分方面的潜力。

相似文献

6
Immunogenicity of coiled-coil based drug-free macromolecular therapeutics.基于螺旋线圈的无药物大分子治疗药物的免疫原性。
Biomaterials. 2014 Jul;35(22):5886-96. doi: 10.1016/j.biomaterials.2014.03.063. Epub 2014 Apr 22.

引用本文的文献

2
Polymer nanomedicines.聚合物纳米药物。
Adv Drug Deliv Rev. 2020;156:40-64. doi: 10.1016/j.addr.2020.07.020. Epub 2020 Jul 28.
7
Tumor-targeting peptides from combinatorial libraries.来自组合文库的肿瘤靶向肽。
Adv Drug Deliv Rev. 2017 Feb;110-111:13-37. doi: 10.1016/j.addr.2016.05.009. Epub 2016 May 19.
8
Design of smart HPMA copolymer-based nanomedicines.基于聚甲基丙烯酸-N-羟丙酯共聚物的智能纳米药物设计。
J Control Release. 2016 Oct 28;240:9-23. doi: 10.1016/j.jconrel.2015.10.003. Epub 2015 Oct 3.
10
Macromolecular therapeutics.大分子疗法
J Control Release. 2014 Sep 28;190:288-303. doi: 10.1016/j.jconrel.2014.04.013. Epub 2014 Apr 18.

本文引用的文献

10
Synthetic molecules as antibody replacements.作为抗体替代物的合成分子。
Acc Chem Res. 2004 Sep;37(9):711-8. doi: 10.1021/ar030145l.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验